Passage BIO (PASG) Other Non Operating Income (2023 - 2026)

Passage BIO's Other Non Operating Income history runs 4 years deep, the most recent figure standing at $688000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 37.45% year-over-year to $688000.0; the TTM figure through Mar 2026 stood at $3.4 million (down 36.4% YoY), while the FY2025 annual figure was $3.8 million, down 32.14% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $688000.0, down from $891000.0 in the prior quarter.
• The five-year high for Other Non Operating Income was $1.7 million in Q4 2023, with the low at $688000.0 in Q1 2026.
• The 4-year median for Other Non Operating Income is $1.4 million (2024), against an average of $1.3 million.
• The sharpest annual moves came in 2024 and 2025: Other Non Operating Income decreased 9.46% in 2024, then tumbled 41.07% in 2025.
• Passage BIO's Other Non Operating Income stood at $1.7 million in 2023, then declined by 11.06% to $1.5 million in 2024, then sank by 41.07% to $891000.0 in 2025, then declined by 22.78% to $688000.0 in 2026.
• Business Quant data shows PASG's Other Non Operating Income at $688000.0 in Q1 2026, $891000.0 in Q4 2025, and $906000.0 in Q3 2025.